Ursolic acid attenuates D-galactose-induced inflammatory response in mouse prefrontal cortex through inhibiting AGEs/RAGE/NF-κB pathway activation

Cerebral Cortex

Volumn 20, Issue 11, 2010, Pages 2540-2548

  Lu, Jun ^a   Wu, Dong Mei ^a   Zheng, Yuan Lin ^a   Hu, Bin ^a   Zhang, Zi Feng ^a   Ye, Qin ^a   Liu, Chan Min ^a   Shan, Qun ^a   Wang, Yong Jian ^a  

^a JIANGSU NORMAL UNIVERSITY   (China)

Author keywords

AGEs; D galactose; inflammatory response; RAGE; ursolic acid

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CARBONYL DERIVATIVE; CD11B ANTIGEN; CYCLOOXYGENASE 2; GALACTOSE; GLIAL FIBRILLARY ACIDIC PROTEIN; INOSINATE DEHYDROGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; URSOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL COUNT; DOWN REGULATION; DRUG ACTIVITY; DRUG MECHANISM; INFLAMMATION; MALE; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION;

ANIMALS; DISEASE MODELS, ANIMAL; GALACTOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; INFLAMMATION; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PREFRONTAL CORTEX; SIGNAL TRANSDUCTION; TRITERPENES;

EID: 77957854250     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhq002     Document Type: Article

References (40)

1. Baynes J, Thorpe S. 1999. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 48:1-9.
2. Beglopoulos V, Sun X, Saura C, Lemere C, Kim R, Shen J. 2004. Reduced {beta}-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J Biol Chem. 279: 46907-46914.
3. Benner E, Mosley R, Destache C, Lewis T, Jackson-Lewis V, Gorantla S, Nemachek C, Green S, Przedborski S, Gendelman H. 2004. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A. 101:9435-9440.
4. Bierhaus A, Humpert P, Morcos M, Wendt T, Chavakis T, Arnold B, Stern D, Nawroth P. 2005. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med. 83:876-886.
5. Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature. 414:813-820.
6. Cai D. 2009. NFkappaB-mediated metabolic inflammation in peripheral tissues versus central nervous system. Cell Cycle. 8:2542-2549.
7. Cai W, He J, Zhu L, Lu C, Vlassara H. 2006. Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proc Natl Acad Sci U S A. 103:13801-13806.
8. Dauer W, Przedborski S. 2003. Parkinson's disease: mechanisms and models. Neuron. 39:889-909.
9. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. 2002. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 23:599-622.
10. Gao HM, Liu B, Zhang WQ, Hong JS. 2003. Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol Sci. 24:395-401.
11. Harmand P, Duval R, Liagre B, Jayat-Vignoles C, Beneytout J, Delage C, Simon A. 2003. Ursolic acid induces apoptosis through caspase-3 activation and cell cycle arrest in HaCat cells. Int J Oncol. 23: 105-112.
12. Huang MT, Ho CT, Wang ZY, Ferraro T, Lou YR, Stauber K, Ma W, Georgiadis C, Laskin JD, Conney AH. 1994. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res. 54:701-708.
13. Ikeda Y, Murakami A, Fujimura Y, Tachibana H, Yamada K, Masuda D, Hirano K, Yamashita S, Ohigashi H. 2007. Aggregated ursolic acid, a natural triterpenoid, induces IL-1beta release from murine peritoneal macrophages: role of CD36. J Immunol. 178:4854-4864.
14. Ikeda Y, Murakami A, Ohigashi H. 2008. Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol Nutr Food Res. 52:26-42.
15. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, et al. 2005. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. 309:481-484.
16. Lee C, Wu S, Chen J, Li C, Lo H, Cheng W, Lin J, Chang Y, Hsiang C, Ho T. 2008. Eriobotrya japonica leaf and its triterpenes inhibited lipopolysaccharide-induced cytokines and inducible enzyme production via the nuclear factor-jB signaling pathway in lung epithelial cells. Am J Chin Med. 36:1185-1198.
17. Lei M, Hua X, Xiao M, Ding J, Han Q, Hu G. 2008. Impairments of astrocytes are involved in the d-galactose-induced brain aging. Biochem Biophys Res Commun. 369:1082-1087.
18. Liu J. 2005. Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol. 100:92-94.
19. Lu J, Wu DM, Hu B, Cheng W, Zheng YL, Zhang ZF, Ye Q, Fan SH, Shan Q, Wang YJ. 2009. Chronic administration of troxerutin protects mouse brain against d-galactose-induced impairment of cholinergic system. Neurobiol Learn Mem. Available online 17 September 2009, doi:10.1016/j.nlm.2009.09.006.
20. Lu J, Zheng YL, Luo L, Wu DM, Sun DX, Feng YJ. 2006. Quercetin reverses d-galactose induced neurotoxicity in mouse brain. Behav Brain Res. 171:251-260.
21. Lu J, Zheng YL, Wu DM, Luo L, Sun DX, Shan Q. 2007. Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by d-galactose. Biochem Pharmacol. 74:1078-1090.
22. Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern DM, Yan SD. 2001. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp Neurol. 171:29-45.
23. Luo Y, Niu F, Sun Z, Cao W, Zhang X, Guan D, Lv Z, Zhang B, Xu Y. 2009. Altered expression of A[beta] metabolism-associated molecules from d-galactose/AlCl3 induced mouse brain. Mech Ageing Dev. 130:248-252.
24. Mallidis C, Agbaje I, Rogers D, Glenn J, McCullough S, Atkinson AB, Steger K, Stitt A, McClure N. 2007. Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitus. Hum Reprod. 22:2169-2177.
25. Ren D, Zuo R, Gonzalez Barrios AF, Bedzyk LA, Eldridge GR, Pasmore ME, Wood TK. 2005. Differential gene expression for investigation of Escherichia coli biofilm inhibition by plant extract ursolic acid. Appl Environ Microbiol. 71:4022-4034.
26. Saeidnia S, Gohari AR, Uchiyama N, Ito M, Honda G, Kiuchi F. 2004. Two new monoterpene glycosides and trypanocidal terpenoids from Dracocephalum kotschyi. Chem Pharm Bull. 52:1249-1250.
27. Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. 2009. Inflammation in Alzheimer's disease: amyloid-[beta] oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol. 87:181-194.
28. Sathyasaikumar K, Swapna I, Reddy P, Murthy C, Dutta Gupta A, Senthilkumaran B, Reddanna P. 2007. Fulminant hepatic failure in rats induces oxidative stress differentially in cerebral cortex, cerebellum and pons medulla. Neurochem Res. 32:517-524.
29. Shinomol GK, Muralidhara. 2007. Differential induction of oxidative impairments in brain regions of male mice following subchronic consumption of Khesari dhal (Lathyrus sativus) and detoxified Khesari dhal. Neurotoxicology. 28:798-806.
30. Singh R, Barden A, Mori T, Beilin L. 2001. Advanced glycation end-products: a review. Diabetologia. 44:129-146.
31. Song X, Bao M, Li D, Li YM. 1999. Advanced glycation in D-galactose induced mouse aging model. Mech Ageing Dev. 108:239-251.
32. Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, Munch G. 2009. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol Aging. Available online 22 May 2009, doi:10.1016/j. neurobiolaging.2009.04.016.
33. Takeda A, Yasuda T, Miyata T, Goto Y, Wakai M, Watanabe M, Yasuda Y, Horie K, Inagaki T, Doyu M, et al. 1998. Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain. Acta Neuropathol. 95:555-558.
34. Tian J, Ishibashi K, Reiser K, Grebe R, Biswal S, Gehlbach P, Handa J. 2005. Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response. Proc Natl Acad Sci U S A. 102:11846-11851.
35. Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT. 1998. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry. 155:1207-1213. (Pubitemid 28402514)
36. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S. 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci. 22:1763-1771.
37. Wu DM, Lu J, Zheng YL, Zhou Z, Shan Q, Ma DF. 2008. Purple sweet potato color repairs d-galactose-induced spatial learning and memory impairment by regulating the expression of synaptic proteins. Neurobiol Learn Mem. 90:19-27.
38. You HJ, Choi CY, Kim JY, Park SJ, Hahm KS, Jeong HG. 2001. Ursolic acid enhances nitric oxide and tumor necrosis factor-[alpha] production via nuclear factor-[kappa]B activation in the resting macrophages. FEBS Lett. 509:156-160.
39. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D. 2008. Hypothalamic IKK[beta]/NF-[kappa]B and ER stress link overnutrition to energy imbalance and obesity. Cell. 135:61-73.
40. Zhang XL, An LJ, Bao YM, Wang JY, Jiang B. 2008. D-galactose administration induces memory loss and energy metabolism disturbance in mice: protective effects of catalpol. Food Chem Toxicol. 46:2888-2894.